dilantin
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.06 (0%) | 🛒 Add to cart |
| 90 | $0.63 | $64.60 $57.08 (12%) | 🛒 Add to cart |
| 120 | $0.58 | $86.13 $69.10 (20%) | 🛒 Add to cart |
| 180 | $0.53 | $129.19 $95.14 (26%) | 🛒 Add to cart |
| 270 | $0.49 | $193.79 $131.19 (32%) | 🛒 Add to cart |
| 360 | $0.48
Best per pill | $258.38 $171.25 (34%) | 🛒 Add to cart |
Synonyms
| |||
Phenytoin, known widely by its brand name Dilantin, is one of the foundational antiepileptic drugs in the neurologist’s arsenal. It’s a hydantoin derivative that’s been stabilizing neuronal membranes and preventing the spread of seizure activity since the 1930s. We’re talking about a drug that, for decades, was the first-line option for tonic-clonic and complex partial seizures. Its role has evolved with the advent of newer agents, but its legacy and specific utility in certain refractory cases keep it relevant. Understanding its pharmacokinetics—the nonlinear metabolism, the protein binding, the narrow therapeutic index—isn’t just academic; it’s the difference between seizure control and toxicity in the clinic.
Key Components and Bioavailability of Dilantin
The active pharmaceutical ingredient is phenytoin sodium, often formulated as 100 mg capsules or a 50 mg/mL suspension. The bioavailability of Dilantin is a critical, and often tricky, aspect. It’s nearly 100% for the capsule when taken orally, but that’s where the simplicity ends. The suspension? That’s a different beast—requires meticulous shaking, and absorption can be erratic if not administered consistently with regard to meals. We learned this the hard way with a patient, Mrs. Gable, whose levels swung wildly until we realized her caregiver wasn’t shaking the bottle. The injectable form, Dilantin IV, is for status epilepticus, but it’s notorious for causing purple glove syndrome and tissue necrosis if extravasation occurs. Its high protein binding (90%) means that small changes in albumin or the presence of other highly protein-bound drugs can dramatically increase the free, active fraction of the drug, leading to toxicity even when the total level appears “therapeutic.”
Mechanism of Action of Dilantin: Scientific Substantiation
So, how does Dilantin work? It’s a use-dependent sodium channel blocker. In simple terms, it stabilizes the inactive state of voltage-gated sodium channels in neurons. When a neuron is firing repetitively, as happens during a seizure focus, Dilantin preferentially binds to the channels and prevents them from returning to their active, ready-to-fire state. This selectively suppresses the high-frequency, sustained firing of neurons that characterizes a seizure, without significantly affecting normal, low-frequency neuronal transmission. It doesn’t boost GABA or directly affect calcium channels like some of the newer drugs. This specific mechanism is why it’s so effective for focal onset and generalized tonic-clonic seizures. I remember a research meeting years ago where we debated if it had secondary messenger effects, but the consensus solidified around the sodium channel blockade as the primary MOA.
Indications for Use: What is Dilantin Effective For?
Dilantin for Tonic-Clonic Seizures
This is its classic indication. For generalized tonic-clonic seizures, it’s highly effective at preventing the violent muscle contractions and loss of consciousness. It was the gold standard for a long time.
Dilantin for Focal (Partial) Seizures
For complex partial seizures, where consciousness is impaired, it can be a robust option, especially in cases where newer agents have failed or aren’t tolerated.
Dilantin for Status Epilepticus
The IV formulation is a second-line agent for benzodiazepine-refractory status epilepticus. You have to administer it slowly to avoid cardiovascular complications like hypotension and bradycardia.
Dilantin for Trigeminal Neuralgia
This is an off-label but well-established use. For that excruciating, lightning-like facial pain, it can be a godsend when carbamazepine isn’t an option.
Instructions for Use: Dosage and Course of Administration
Dosing Dilantin is an art form because of its saturable, zero-order kinetics. A small increase in dose can lead to a massive, disproportionate increase in serum concentration. You don’t just double the dose; you creep up on it.
| Indication | Typical Adult Loading Dose | Typical Adult Maintenance Dose | Key Administration Notes |
|---|---|---|---|
| Status Epilepticus | 15-20 mg/kg IV (slow infusion) | N/A | Monitor ECG and BP during infusion. |
| Initiation of Therapy | N/A | 3-5 mg/kg/day in divided doses (TID) | Start low, check levels in 1-2 weeks. |
| Established Therapy | N/A | Highly individualized (300-400 mg/day common) | Once-daily dosing possible with extended-release. |
For kids, it’s weight-based, usually 5-10 mg/kg/day. The suspension must be shaken vigorously. We always tell parents to use an oral syringe, not a household spoon. The goal is a steady-state concentration between 10-20 mcg/mL. Anything above 20 and you’re flirting with nystagmus, ataxia, and lethargy; above 30, and you risk coma.
Contraindications and Drug Interactions with Dilantin
Absolute contraindications? Sinus bradycardia, SA block, and 2nd/3rd degree AV block are big ones due to its effects on the cardiac conduction system. A history of hypersensitivity to phenytoin or other hydantoins is a hard stop—that rash can progress to Stevens-Johnson or DRESS syndrome, which is a nightmare.
The drug interactions list is a mile long. It’s a potent inducer of hepatic CYP enzymes (CYP2C9, CYP2C19, CYP3A4). It’ll chew up and spit out oral contraceptives, warfarin, cyclosporine, and many antidepressants, rendering them less effective. Conversely, drugs that inhibit these enzymes, like fluconazole, amiodarone, or cimetidine, can send phenytoin levels skyrocketing. Then there’s the protein-binding displacement war with drugs like valproate—they kick phenytoin off its albumin binding sites, increasing the free fraction and potential for toxicity even if the total level looks okay. It’s a constant juggling act.
Clinical Studies and Evidence Base for Dilantin
The evidence for Dilantin is decades deep, built on a foundation of older but robust clinical trials. The VA Cooperative Studies in the 1980s and 90s cemented its place, showing efficacy rates of over 60% for controlling tonic-clonic seizures. A more modern analysis, a 2019 Cochrane review, concluded that phenytoin remains effective for generalized tonic-clonic and focal seizures, though it noted a higher burden of adverse effects and drug interactions compared to newer AEDs like levetiracetam. For status epilepticus, the landmark Rapid Anticonvulsant Medication Prior to Arrival Trial (RAMPART) established intramuscular midazolam as superior to IV lorazepam, but phenytoin/fosphenytoin remains a standard second-line agent in protocols worldwide after benzodiazepines fail. The data is less robust but still persuasive for its use in neuropathic pain conditions.
Comparing Dilantin with Similar Products and Choosing a Quality Product
When you stack Dilantin against levetiracetam (Keppra), the differences are stark. Keppra has a much more favorable interaction profile, linear kinetics, and is generally better tolerated in terms of cosmetic side effects and gingival hyperplasia. But Dilantin is often more sedating, which can be a therapeutic advantage in some agitated patients. Compared to carbamazepine, another sodium channel blocker, Dilantin has a lower risk of hyponatremia but a higher risk of cosmetic and cognitive side effects. Valproate has a broader spectrum of action but comes with weight gain and teratogenicity concerns.
Choosing a product? Brand-name Dilantin versus generics can be a real debate. The FDA considers them bioequivalent, but we’ve all seen cases—like a patient of mine, Mr. Hopkins—who seized after a pharmacy switched his manufacturer. For a drug with such a narrow therapeutic window, that tiny variability in dissolution can be clinically significant. If a patient is stable on a specific manufacturer’s product, I fight to keep them on it.
Frequently Asked Questions (FAQ) about Dilantin
What is the recommended course of Dilantin to achieve results?
Therapy is typically long-term, often for years or life. You initiate therapy, titrate to a dose that achieves a serum level of 10-20 mcg/mL and provides seizure freedom, and then maintain that dose with periodic level checks.
Can Dilantin be combined with other seizure medications?
Yes, it’s often used in polytherapy, but you must be hyper-vigilant about interactions. Combining it with valproate requires careful monitoring of free phenytoin levels. Using it with CNS depressants like benzodiazepines can compound sedation.
What are the long-term side effects of Dilantin?
Long-term, you’re looking at cosmetic changes: coarsening of facial features, hirsutism, gingival hyperplasia. There’s also the risk of peripheral neuropathy, osteoporosis from altered vitamin D metabolism, and cerebellar atrophy with chronic toxicity.
Is Dilantin safe during pregnancy?
It’s a Pregnancy Category D drug. It’s associated with a specific pattern of birth defects known as the “fetal hydantoin syndrome,” which can include craniofacial abnormalities and cardiac defects. The risk-benefit must be carefully weighed, and it’s generally avoided in women of childbearing potential if other options exist.
Conclusion: Validity of Dilantin Use in Clinical Practice
So, where does that leave us with Dilantin? It’s not the shiny new tool in the box, but it’s a reliable, powerful, and cost-effective one. Its validity in clinical practice is undeniable for specific situations: refractory focal seizures, status epilepticus, and as a legacy drug for patients who have been stable on it for decades. The risk-benefit profile tips towards “benefit” when you need the specific action of a sodium channel blocker and can manage its fickle pharmacokinetics and significant side effect profile. For a new-onset epilepsy patient today, we might reach for something else first, but to dismiss Dilantin entirely would be to ignore a profound chapter in neurology.
I’ll never forget the first time I saw Dilantin work its magic. It was during my residency, a night shift. We had a guy, Leo, in his 50s, a known epileptic found down after a cluster of tonic-clonics. He was post-ictal, groaning. The attending, Dr. Shaw, a gruff old-school neurologist, barked for a loading dose of Dilantin. I was skeptical—this wasn’t status, why not just his home meds? But we pushed the IV, slowly. Over the next few hours, Leo didn’t just stop seizing; the agitated, post-ictal confusion lifted. He became calm, oriented. He asked for a cup of tea. Dr. Shaw just nodded at me. “See? Still has its place.” We later discovered his family had run out of his Keppra a few days prior. The Dilantin bridge held him until we could get him back on his regular regimen.
Then there was Sarah, a 28-year-old with refractory trigeminal neuralgia. Carbamazepine made her lethally neutropenic. Gabapentin, pregabalin—nothing touched the pain. She was desperate, talking about surgical ablation. As a team, we were divided. My junior colleague was adamant we try a newer agent, citing the side effect profile. I argued for a trial of low-dose phenytoin, based on some old papers. We went with it, hesitantly. The first week, she reported a 30% reduction in pain paroxysms. By week three, it was 70%. The trade-off? Mild gum hyperplasia, which our dental colleagues managed with intensive hygiene. At her 6-month follow-up, she cried—happy tears—saying it gave her her life back. It was a reminder that sometimes the old tools, for all their rough edges, fit a lock that newer, sleeker keys can’t. We still check her levels every 3 months, and her gums, but she’s been pain-free for over a year now. She sends me a Christmas card every year. That’s the real-world evidence that never makes it into the journals.